Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 79, Issue 3, 1994, Pages 872-878

  Brismar, Kerstin ^a   Fernqvist Forbes, Eva ^a   Wahren, John ^a   Hall, Kerstin ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; GROWTH HORMONE; INSULIN; ISOPHANE INSULIN; NEUTRAL INSULIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DRUG EFFECT; HEPATIC ARTERY; HEPATIC VEIN; HUMAN; HYPOINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIVER METABOLISM; MALE; PERIPHERAL VEIN; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ADULT; CARRIER PROTEINS; DIABETES MELLITUS, INSULIN-DEPENDENT; GLUCAGON; GLUCOSE; HEPATIC VEINS; HUMAN; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH-FACTOR-BINDING PROTEINS; KINETICS; LIVER; MALE; SPLANCHNIC CIRCULATION; SUPPORT, NON-U.S. GOV'T;

EID: 0028000737     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.79.3.7521354     Document Type: Article

References (37)

1. Baxter RC. 1993 Circulating binding proteins for the insulin-like growth factors. TEM. 4:91-96.
2. Lee PDK, Conover CA, Powell DR. 1993 Regulation and function of insulin-like growth factor-binding protein-1 [Minireview]. Proc Soc Exp Biol Med. 204:4-29.
3. Bang P, Hall K. 1992 Insulin-like growth factors as endocrine and paracrine hormones. In: Schofield PN, ed. The insulin-like growth factors: structures and biological function. Oxford: Oxford University Press; 151-177.
4. Baxter RC, Martin JL, Beniac VA. 1989 High molecular weight insulin-like growth factor binding protein complexes: purification and protein properties of the acid-labile subunit from human serum. J Biol Chem. 264:11843-11848.
5. Hall K, Brismar K, Grissom F, Lindgren B, Povoa G. 1991 IGFBP-1. Production and control mechanisms. Acta Endocrinol (Copenh). 124:46-54.
6. Bar RS, Boes M, Clemmons DR, et al. 1990 Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart. Endocrinology. 127:497-499.
7. Bar RS, Clemmons DR, Boes M, et al. 1990 Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid (IGFBP-1) IGF-binding proteins in the rat heart. Endocrinology. 127:1078-1082.
8. Brismar K, Hall K. 1993 Clinical application of IGFBP-1 and its regulation. Growth Regul. 3:98-100.
9. Brismar K, Gutniak M, Povoa G, Werner S, Hall K. 1988 Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus. J Endocrinol Invest. 11:599-602.
10. Batch JA, Baxter RC, Werther G. 1991 Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab. 73:964-968.
11. Holly JMP, Biddlecome RA, Dunger DB, et al. 1988 Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin Endocrinol (Oxf). 29:667-675.
12. Suikkari AM, Koivisto VA, Koistonen R, Seppala M, Yki-Jarvinen H. 1989 Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. J Clin Endocrinol Metab. 68:135-140.
13. Brismar K, Grill V, Efendic S, Hall K. 1991 The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatment. Metabolism. 40:728-732.
14. D'Ercole AJ, Stiles AD, Underwood LE. 1984 Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad SciUSA. 81:935-939.
15. Guler H-P, Zapf J, Schmid C, Froesch ER. 1989 Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh). 121:753-758.
16. De Fronzo RA, Tobin JD, Andres R. 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237:E214-E223.
17. Povoa G, Roovete A, Hall K. 1984 Crossreaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol (Copenh). 107:563-570.
18. Bang P, Eriksson U, Sara V, Wivall IL, Hall K. 1991 Comparison of add ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determination in acid ethanol extracts by use of truncated IGF-I as radioligand. Acta Endocrinol (Copenh). 124:620-629.
19. Grill V, Pigon J, Hartling SG, Binder C, Efendic S. 1990 Effects of dexamethasone in glucose induced insulin and proinsulin release in low and high responders. Metabolism. 39:251-258.
20. Falcona GR, Unger RH. 1974 Glucagon radioimmunoassay technique. In: Jaffe BM, Behrman HE, eds. Methods of hormone radioimmunoassay. New York: Academic Press; 317-330.
21. Powell DR, Suwanichkiul A, Cubbage ML, De Paolis LA, Snuggs MB, Lee PDK. 1991 Insulin inhibits transcription of the human gene for insulin-like growth factor binding protein-1. J Biol Chem. 226:18868-18876.
22. Lindgren B, Isaksson M, Stern I, Hall K. 1993 Insulin-like growth factor binding protein-1 from Hep G2 cells is potently inhibited by the truncated IGF-1 analogue des-(l-3) IGF-I. Acta Endocrinol (Copenh). 128:81-87.
23. Conover CH, Butler P, Wang M, Rizza R, Lee P. 1990 Lack of growth hormone effect on insulin-associated suppression of insulinlike growth factor binding protein 1 in humans. Diabetes. 39:1251-1256.
24. Fowelin J, Attwall S, von Schenck H, Smith U, Lager I, Hall K. Regulation of insulin-like growth factor binding protein-1 (IGFBP-1) in insulin-dependent diabetes mellitus-effects of hyperglycemia and insulin. Diabetes. In press.
25. Hilding A, Brismar K, Thoren M, Hall K. 1993 Glucagon stimulates IGFBP-1 secretion in healthy subjects, patients with pituitary insufficiency and patients with insulin dependent diabetes mellitus. J Clin Endocrinol Metab. 77:1142-1147.
26. Rieu M, Binoux M. 1985 Serum levels of insulin-like growth factor (IGF) and IGF binding protein in insulin-dependent diabetics during an episode of severe metabolic decompensation and the recovery phase. J Clin Endocrinol Metab. 60:781-785.
27. Hall K, Johansson BL, Povoa G, Thalme B. 1989 Serum levels of insulin-like growth factor (IGF) I, II and IGF binding protein in diabetic adolescents treated with continuous subcutaneous insulin infusion. J Intern Med. 225:273-278.
28. Maiter D, Fliesen T, Underwood LE, et al. 1989 Protein restriction decreases insulin-like growth factor I independent of insulin and liver growth hormone binding. Endocrinology. 124:2604-2611.
29. Walker JL, Ginalska-Malinowska M, Römer TE, Pucilowska JB, Underwood LE. 1992 Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism). N Engl J Med. 324:1483-1487.
30. Kanety H, Karasik A, Klinger B, et al. 1993 Long-term treatment of Laron type dwarfism with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity. Acta Endocrinol (Copenh). 128:144149.
31. Thoren M, Wivall-Helleryd IL, Hall K. 1993 Effects of recombinant human insulin-like growth factor I administration in adults with growth hormone deficiency. Acta Paediatr. 388(Suppl):45-48.
32. Taylor AM, Dünger DB, Preece MA, et al. 1990 The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent inulin-dependent diabetics. Clin Endocrinol (Oxf). 32:229-239.
33. Lewitt M, Denyer GS, Cooney GJ, Baxter RC. 1991 Insulin-like growth factor binding-protein-1 modulated blood glucose levels. Endocrinology. 129:2254-2256.
34. Hall K, Lundin G, Povoa G. 1988 Serum levels of the low molecular weight form of insulin-like growth factor binding protein in healthy subjects and patients with growth hormone deficiency, acromegaly and anorexia nervosa. Acta Endocrinol (Copenh). 119:321-326.
35. Bang P, Brismar K, Rosenfeld RG, Hall K. 1994 Fasting affects serum insulin-like growth factors (IGFs) and IGF binding proteins differently in patients with NIDDM versus non-obese and obese, weight matched healthy subjects. J Clin Endocrinol Metab. 78:960-967.
36. Arias P, Kerner W, de la Fuente A, Pfeiffer EF. 1984 Abnormal growth hormone levels in insulin-dependent patients under continuous subcutaneous insulin infusion and intensified conventional treatment. Acta Endocrinol (Copenh). 107:250-255.
37. Schaper NC. 1992 Growth hormone secretion in type I diabetes: a review. Acta Endocrinol (Copenh). 122(Suppl 1):7-12.